Work

A First-in-Man Phase I and Pharmacokinetic Study on CHR-2797 (Tosedostat), an Inhibitor of M1 Aminopeptidases, in Patients with Advanced Solid Tumors

Year: 2009

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-09-0306

Authors: Alison H.M. Reid, Andrew Protheroe, Gerhardt Attard, Nikki Hayward, Laura Vidal, James Spicer, Heather M. Shaw, Elizabeth A. Bone, Joanne Carter, Leon Hooftman, Adrian Harris, Johann S. De Bono

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Churchill Hospital, Royal Marsden Hospital

Language: English

Topic: Peptidase Inhibition and Analysis

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Royal Marsden NHS Foundation Trust, National Institute for Health and Care Research

Award: G2519382346

OpenAlex ID: W2084162137

FWCI: 1.164

Cites: 23

Cited by: 35

Related to: 10